UK Circulating Tumor Cells Market Size & Outlook
UK circulating tumor cells market, 2018-2030 (US$M)
Related Markets
UK circulating tumor cells market highlights
- The UK circulating tumor cells market generated a revenue of USD 692.6 million in 2023 and is expected to reach USD 1,926.9 million by 2030.
- The UK market is expected to grow at a CAGR of 15.7% from 2024 to 2030.
- In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2023.
- CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
Circulating tumor cells market data book summary
| Market revenue in 2023 | USD 692.6 million |
| Market revenue in 2030 | USD 1,926.9 million |
| Growth rate | 15.7% (CAGR from 2023 to 2030) |
| Largest segment | Ctc detection & enrichment methods |
| Fastest growing segment | CTC Analysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
| Key market players worldwide | Qiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, UK accounted for 6.0% of the global circulating tumor cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK circulating tumor cells market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,926.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Circulating Tumor Cells Market Scope
Circulating Tumor Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK circulating tumor cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 65.69% in 2023. Horizon Databook has segmented the UK circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is considered to be a good entry point to Europe for branded generic manufacturers. This can be attributed to factors such as high generics penetration (approximately 70% by volume), low entry barriers, and relatively simplified entry requirements.
However, sustaining in the UK market can be difficult for branded generics players, as there is high dominance of unbranded generics in the UK market. This impedes the opportunity to differentiate by company brand or product; thereby, manufacturers are mainly dependent on pricing.
Moreover, physicians are mandated to prescribe according to International Nonproprietary Name (INN) in the UK. However, according to a research study, around 82% of all prescriptions are prescribed according to INN, which could slow down the branded generics growth compared to unbranded generics.
Reasons to subscribe to UK circulating tumor cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK circulating tumor cells market databook
-
Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK circulating tumor cells market , including forecasts for subscribers. This country databook contains high-level insights into UK circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK circulating tumor cells market size, by technology, 2018-2030 (US$M)
UK Circulating Tumor Cells Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
